9-136011875-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144653.5(NACC2):āc.1405G>Cā(p.Val469Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000051 in 1,568,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144653.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NACC2 | NM_144653.5 | c.1405G>C | p.Val469Leu | missense_variant | 6/6 | ENST00000277554.4 | NP_653254.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NACC2 | ENST00000277554.4 | c.1405G>C | p.Val469Leu | missense_variant | 6/6 | 1 | NM_144653.5 | ENSP00000277554.2 | ||
NACC2 | ENST00000371753.5 | c.1405G>C | p.Val469Leu | missense_variant | 5/5 | 1 | ENSP00000360818.1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152228Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000785 AC: 14AN: 178414Hom.: 0 AF XY: 0.0000826 AC XY: 8AN XY: 96896
GnomAD4 exome AF: 0.0000268 AC: 38AN: 1416754Hom.: 0 Cov.: 33 AF XY: 0.0000228 AC XY: 16AN XY: 702040
GnomAD4 genome AF: 0.000276 AC: 42AN: 152228Hom.: 0 Cov.: 34 AF XY: 0.000269 AC XY: 20AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2023 | The c.1405G>C (p.V469L) alteration is located in exon 6 (coding exon 5) of the NACC2 gene. This alteration results from a G to C substitution at nucleotide position 1405, causing the valine (V) at amino acid position 469 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at